Cancer driver mutations: predictions and reality
D Ostroverkhova, TM Przytycka… - Trends in Molecular …, 2023 - cell.com
Cancer cells accumulate many genetic alterations throughout their lifetime, but only a few of
them drive cancer progression, termed driver mutations. Driver mutations may vary between …
them drive cancer progression, termed driver mutations. Driver mutations may vary between …
Mutational signatures: From methods to mechanisms
YA Kim, MDM Leiserson, P Moorjani… - Annual Review of …, 2021 - annualreviews.org
Mutations are the driving force of evolution, yet they underlie many diseases, in particular,
cancer. They are thought to arise from a combination of stochastic errors in DNA processing …
cancer. They are thought to arise from a combination of stochastic errors in DNA processing …
Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy
D Mas-Ponte, M McCullough, F Supek - Clinical Science, 2022 - portlandpress.com
Genome sequencing can be used to detect DNA repair failures in tumors and learn about
underlying mechanisms. Here, we synthesize findings from genomic studies that examined …
underlying mechanisms. Here, we synthesize findings from genomic studies that examined …
MUSE-XAE: MUtational Signature Extraction with eXplainable AutoEncoder enhances tumour types classification
Motivation Mutational signatures are a critical component in deciphering the genetic
alterations that underlie cancer development and have become a valuable resource to …
alterations that underlie cancer development and have become a valuable resource to …
Accurate and sensitive mutational signature analysis with MuSiCal
Mutational signature analysis is a recent computational approach for interpreting somatic
mutations in the genome. Its application to cancer data has enhanced our understanding of …
mutations in the genome. Its application to cancer data has enhanced our understanding of …
[HTML][HTML] Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency
YN Kim, DC Gulhan, H Jin… - Cancer Research and …, 2024 - synapse.koreamed.org
Accurate detection of homologous recombination deficiency (HRD) in cancer patients is
paramount in clinical applications, as HRD confers sensitivity to poly (ADP-ribose) …
paramount in clinical applications, as HRD confers sensitivity to poly (ADP-ribose) …
Identification of multiplicatively acting modulatory mutational signatures in cancer
Background A deep understanding of carcinogenesis at the DNA level underpins many
advances in cancer prevention and treatment. Mutational signatures provide a breakthrough …
advances in cancer prevention and treatment. Mutational signatures provide a breakthrough …
Emerging topics in cancer evolution
Cancer results from an evolutionary process that yields a heterogeneous tumor with distinct
subpopulations and varying sets of somatic mutations. This perspective discusses …
subpopulations and varying sets of somatic mutations. This perspective discusses …
[PDF][PDF] Developing Clinical Potential of Mutational Signatures: Insights from Formalin-Fixed Biopsies and MSI-High Tumours
Q Guo - 2023 - helda.helsinki.fi
The advancement of cancer is driven by the accumulation of somatic mutations arising from
various mutational processes within the individual's lifetime. A specific mutational process …
various mutational processes within the individual's lifetime. A specific mutational process …
Decomposing the mutational landscape of cancer genomes with RepairSig
S Bernardo, M Meyenberg, JI Loizou - Cell Systems, 2021 - cell.com
Mutational signatures are the outcomes of mutagenic processes that occur prior to, and
during, tumorigenesis as a result of DNA damage, DNA repair, and DNA replication. In this …
during, tumorigenesis as a result of DNA damage, DNA repair, and DNA replication. In this …